A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection

A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection

The restoration of innate immune responses has potential as a novel therapeutic strategy for chronic hepatitis C (CHC). We compared the efficacy and safety of induction therapy (IT) with natural interferon-β (n-IFN-β) followed by pegylated-IFN-α/ribavirin (PR) alone (group A, n = 30) and IT with a p...

Full description

Bibliographic Details
Main Authors: Yutaka Kishida, Naohiko Imaizumi, Hirohisa Tanimura, Shinichiro Kashiwamura, Toru Kashiwagi
Format: Article
Language:English
Published: MDPI AG 2016-03-01
Series:International Journal of Molecular Sciences
Subjects:
chronic hepatitis C
protease inhibitor
Peg-IFN-α
ribavirin
interferon-β
induction therapy
Online Access:http://www.mdpi.com/1422-0067/17/3/350

Internet

http://www.mdpi.com/1422-0067/17/3/350

Similar Items